Dataset Information

Targeting Regulatory T Cells Promotes Post-Infarction Cardiac Repair Through IFIT1-Mediated Reprogramming of Reparative Mesenchymal Stem Cells

ABSTRACT: Early transplantation of mesenchymal stem cells (MSCs) showed promise in rescuing cardiac function and alleviating ventricular remodeling post-myocardial infarction (MI) while regulatory T cells (Treg) either. However, the crosstalk between them remains fully elusive. To explore mechanisms optimizing MSC therapy from Treg immunoregulatory and develop potential therapeutic targets, adipose-derived stem cells (ADSCs), an easily accessible MSC, were applied. The Treg depletion diminished the cardioprotective effects of ADSCs, causing both systolic dysfunction and cardiac fibrosis. Tregs promoted ADSC retention by proliferation and migration activation with further myogenic differentiation. RNA-sequencing analysis revealed Treg co-culture induced a myogenic differentiation mRNA profile in ADSCs, significantly downregulating Ifit1. IFIT1 downregulation resulted in cardiomyocyte-like differentiation in ADSCs, evidenced by increased myogenic markers and spontaneous beating. Mechanistically, IFIT1 knockdown provoked upregulation of E2F1 protein without altering E2f1 mRNA levels. IFIT1 specifically bound to E2f1 mRNA to inhibit translation, reducing polysomes while knockdown introduced myogenic translational profile. The rAAV9-sh-Ifit1 injection restored systolic dysfunction, reduced fibrosis, and attenuated cardiac hypertrophy. This study uncovered a novel mechanism whereas Tregs potentiated the therapeutic efficacy of ADSCs in MI by downregulating IFIT1, thereby promoting E2f1 translation and myogenic differentiation, offering a potential target to improve cardiac repair strategies.

ORGANISM(S): Mus musculus

PROVIDER: GSE284366 | GEO | 2024/12/16

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:To find which genes were significantly modulated by Valsartan in non-infarcted left ventricle, 4 weeks after coronary artery ligation, and to correlate emerging modulated pathways with histology and cardiac magnetic resonance (CMR) imaging. The goal was to validate the estimation of the systolic dysfunction and of the regions preserved by pharmacological treatment performed with a CMR index. Title of the associated submitted paper: Evaluation of left ventricle function by regional fractional area change (RFAC) in a mouse model of myocardial infarction secondary to Valsartan treatment. Abstract: Purpose: Left ventricle (LV) regional fractional area change (RFAC) measured by cardiac magnetic resonance (CMR) allows the non-invasive localization and quantification of the extent of myocardial infarction (MI), and could be applied to assess the effectiveness of pharmacological or regenerative therapies. Here we investigate the ability of RFAC to identify regional dysfunction and discriminate the effect of pharmacological treatment with valsartan, a selective antagonist of angiotensin II type 1 receptor, in a model of MI. Methods: C57BL/6N mice, undergoing coronary artery ligation, were divided into two groups: untreated (MI) or treated with Valsartan (MI+Val). Sham-operated mice were used as a control. Cardiac dimensions and function were assessed at baseline, 24 hours, 1 and 4 weeks post surgery by CMR and echocardiography. At sacrifice histology and whole-genome gene expression profiling were performed. Results: RFAC was able to detect significant differences between treatment groups whereas the global ejection fraction was not. RFAC showed greater loss of contractility in remote non-infarcted myocardium in MI group than in MI+Val group. Consistently, in the same region MI+Val mice showed reduced myocyte hypertrophy, fibroblast proliferation, and fibrosis and modulation of target genes; in addition, left atrium volumes, appendage length and duct contractility were preserved. Conclusion: In this study, RFAC effectively estimated the degree of systolic dysfunction and discriminated the regions preserved by pharmacological treatment. RFAC index is a promising tool to monitor changes in LV contractility and to assess the effectiveness of therapeutic regimens in clinical settings.

Dataset Information

Targeting Regulatory T Cells Promotes Post-Infarction Cardiac Repair Through IFIT1-Mediated Reprogramming of Reparative Mesenchymal Stem Cells

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets